Aspiriant, LLC Gsk PLC Transaction History

Aspiriant, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 01, 2021	SELL	$34.07 - $39.94 $211,234 - $247,628	-6,200 Closed	0 $0
Q3 2020 Oct 29, 2020	BUY	$38.11 - $42.99 $236,282 - $266,538	6,200 New	6,200 $233,000
Q2 2018 Aug 07, 2018	SELL	$39.61 - $42.76 $249,543 - $269,388	-6,300 Closed	0 $0
Q1 2018 May 04, 2018	BUY	$36.18 - $40.15 $227,934 - $252,945	6,300 New	6,300 $246,000

167K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $78B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Aspiriant, LLC, based on Form 13F filings with the SEC.

Stay updated on Aspiriant, LLC with notifications on news.